Ding-Yuan Wang (Dingyuan Wang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Top Venues

Scientific reports

Cancer medicine

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Wang, Ding-Yuan Wang, Ke-Na Bu, Ji-Dong Gao, Bai-Lin Zhang
Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature. Scientific reports 14 (1) (2024)
Yang Wang, Ding-Yuan Wang, Ke-Na Bu, Ji-Dong Gao, Bai-Lin Zhang
Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature. Scientific reports 14 (1) (2024)
Yang Wang, Ding-Yuan Wang, Ke-Na Bu, Ji-Dong Gao, Bai-Lin Zhang
Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature. Scientific reports 14 (1) (2024)
Shuofeng Li, Ding-Yuan Wang, Ran Wei, Guanhua Yu, Xishan Wang, Zheng Jiang
Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy. Technology in cancer research & treatment 22 (2023)
Ding-Yuan Wang, Shuo-Feng Li, Song-Lin Gao, Peng Yuan, Bai-Lin Zhang
Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population-based study from China. Cancer medicine (2023)
Ding-Yuan Wang, Songlin Gao, Haili Qian, Peng Yuan, Bai-Lin Zhang
Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration Model. Cancers 14 (17) (2022)
Shu-Tao Ma, Ding-Yuan Wang, Yi-Bing Liu, Hui-Jing Tan, Yue-Yue Ge, Yihebali Chi, Bai-Lin Zhang
Prognostic factors of primary neuroendocrine breast cancer: A population-based study. Cancer medicine 11 (13) (2022)
Huijing Tan, Lijie Zuo, Shutao Ma, Ding-Yuan Wang, Rui Li, Yiqi Yang, Weili Liu, Yihebali Chi
Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma. Cancer management and research 13 (2021)